|

|

|

|

|

|

OncoGenerix, Mudanjiang’s premier manufacturing site.

Who We Are

Located in the scenic Heilongjiang Province in the north eastern part of China, OncoGenerix has a fully self-contained aseptic manufacturing site offering contract manufacturing services in compliance with SFDA (China), US FDA (United States) and European Medicines Agency. The OncoGenerix Mudanjiang manufacturing site is 40,110m2 with approximately 18,300 m2 of facilities, including:

  • Production Facility (5,700M^2)
  • GMP Warehouse (1,200M^2)
  • Central Utilities Building (1,100M^2)
  • Staff Accommodation Facility (1,500M^2 Completion July 2015)
  • Administration/Development Lab Facility (11,600M^2 Completion May 2016)

With a fully integrated Western and Chinese team, OncoGenerix offers isolator based aseptic filling, lyophilization, capping, inspection and packing contract manufacturing services to the global pharmaceutical industry.

Why choose us

Quality & Compliance

Self Sufficiency

Flexibility & Scalability

Environmental Commitment

Customer Service

Communication

Open Source

Diversity Of Knowledge

250
Salaried Employees
40 K
Production Facility (m2)
30 mil
Vials Per Yer
20 %
Less Bioburden
OncoGenerix